High Altitude & Exogenous Carbohydrate Oxidation

Status Completed

Clinical Trial Summary

Recent studies have reported that oxidation of exogenous carbohydrate is reduced under acute hypobaric hypoxic (high altitude; HA) conditions compared to normoxia (sea level; SL) in native lowlanders. However, the mechanisms by which HA suppresses exogenous carbohydrate oxidation are not known. This study will seek to confirm that acute HA exposure decreases exogenous carbohydrate oxidation during steady-state aerobic exercise compared to SL, and explore if the mechanism inhibiting plasma glucose uptake is insulin dependent or independent.

Clinical Trial Description

This randomized crossover study will examine substrate metabolic responses to ingesting supplemental carbohydrate during steady-state aerobic-type exercise at sea level (SL) and following acute (~5 h) exposure to HA (4,300 m) conditions in 10 healthy, recreationally active adults between the ages of 18-39 yrs. Following a 48-hr muscle glycogen normalization period, volunteers will complete 80-min of metabolically-matched, steady-state aerobic exercise on a treadmill, and consume 145 g of glucose (1.8 g·min-1) at SL and HA. Treadmill exercise will be performed at the same absolute workload, with speed and grade being the same at SL and HA to induce the same absolute workload between phases. SL and HA trials will occur in the US Army Research Institute of Environmental Medicine (USARIEM) hypobaric chamber and will be separated by a minimum 7-d washout period between each protocol day. 6-6-[2H2] glucose will be used as a tracer to assess glucose turnover. Indirect calorimetry, breath sampling for 13C/12C expired in CO2, and urine collections will be used to determine carbohydrate, fat, and protein oxidation during exercise at SL and HA. Serial blood draws will be collected during each trial to assess endocrine and circulating substrate responses to exercise, carbohydrate, and hypoxia. Muscle biopsies will be collected before and after steady-state exercise to examine intramuscular glucose transport expression and translocation, glycogen status, and activity enzyme intermediates in aerobic and anaerobic energy metabolism. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03851744
Study type	Interventional
Source	United States Army Research Institute of Environmental Medicine
Contact
Status	Completed
Phase	N/A
Start date	November 28, 2018
Completion date	September 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04120051` - The SIMBA Project - The Effect of a Prebiotic Supplement on Glucose Metabolism and Gut Microbiota in Obese Adults	N/A
Completed	`NCT01686815` - Cross-Sectional Iloperidone IVGTT
Completed	`NCT01034293` - Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning	N/A
Completed	`NCT05642052` - Feasibility Study of a Community Pilot Project for the Prevention of Alzheimer's Disease: the KetoHome Study.	N/A
Completed	`NCT05801731` - A Decentralized Study on Dietary Influences on Cognitive Functions	N/A
Completed	`NCT04611945` - Westlake Sailing Cohort
Active, not recruiting	`NCT04737694` - Ketone Supplements and Substrate Oxidation and Physical Performance	N/A
Completed	`NCT05282641` - Effects of 10-gram Collagen Protein Hydrolysate on Cardiometabolic Health	N/A
Completed	`NCT03648112` - Effects of Beta-glucan From Barley and Oats on Glucose and Lipid Metabolism, and Satiety	N/A
Recruiting	`NCT04851041` - Effects of a Potato-based Food Pattern vs a Rice / Pasta-based Food Pattern on Cardiometabolic Health	N/A
Completed	`NCT05313594` - Digital Twin - Modelling Postprandial Triglyceride and Glucose Responses
Active, not recruiting	`NCT01390688` - Brain-derived Neurotrophic Factor and Cogntive Function	N/A
Recruiting	`NCT00953966` - Metabolic Changes Induced by Genetically Modified Potatoes	N/A
Completed	`NCT04928872` - Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
Completed	`NCT02854709` - Effects of Sleep Extension on Glucose Metabolism in Chronically Sleep Deprived Individuals	N/A
Completed	`NCT00227500` - Pravastatin for Hyperlipidaemia in HIV.	Phase 4
Recruiting	`NCT04894526` - Alternating Energy Intake and Blood Fat Content After a Meal	N/A
Recruiting	`NCT04971408` - Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury	N/A
Terminated	`NCT04234009` - Lifestyle and Brain Vascular Function	N/A
Completed	`NCT01877460` - Sodium Alginate in Chocolate Milk, Satiety and Glycemic Control	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

High Altitude and Exogenous Carbohydrate Oxidation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms